Spots Global Cancer Trial Database for blastic plasmacytoid dendritic cell neoplasm (bpdcn)
Every month we try and update this database with for blastic plasmacytoid dendritic cell neoplasm (bpdcn) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. | NCT05645744 | Blastic Plasmac... Chronic Lymphoc... Small Lymphocyt... Waldenstrom's M... Follicular B-ce... B-cell Lymphoma... Mantle Cell Lym... Hairy Cell Leuk... Diffuse Large B... Waldenstrom's M... Mantle Cell Lym... | Prior MB-102 CA... Prior MB-106 CA... | 18 Years - | Mustang Bio | |
| Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm | NCT06006403 | Acute Myeloid L... Blastic Plasmac... Relapse Leukemi... Refractory Leuk... | CD123 targeted ... | 18 Years - 75 Years | Chongqing Precision Biotech Co., Ltd | |
| Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. | NCT04109482 | Blastic Plasmac... | MB-102 Fludarabine Cyclophosphamid... | 18 Years - | Mustang Bio | |
| Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. | NCT05645744 | Blastic Plasmac... Chronic Lymphoc... Small Lymphocyt... Waldenstrom's M... Follicular B-ce... B-cell Lymphoma... Mantle Cell Lym... Hairy Cell Leuk... Diffuse Large B... Waldenstrom's M... Mantle Cell Lym... | Prior MB-102 CA... Prior MB-106 CA... | 18 Years - | Mustang Bio | |
| Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry | NCT05430971 | Blastic Plasmac... | - | Immune Oncology Research Institute | ||
| Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies | NCT04013685 | Acute Myeloid L... Acute Lymphoid ... Myelodysplastic... Acute Leukemia Blastic Plasmac... Chronic Myeloid... | Orca-T | 18 Years - 75 Years | Orca Biosystems, Inc. | |
| SL-401 in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia | NCT02113982 | Blastic Plasmac... Acute Myeloid L... | SL-401 | 18 Years - | Stemline Therapeutics, Inc. | |
| Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN | NCT03203369 | Blastic Plasmac... | UCART123 | 18 Years - 80 Years | Cellectis S.A. | |
| Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN | NCT03203369 | Blastic Plasmac... | UCART123 | 18 Years - 80 Years | Cellectis S.A. | |
| Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm | NCT06006403 | Acute Myeloid L... Blastic Plasmac... Relapse Leukemi... Refractory Leuk... | CD123 targeted ... | 18 Years - 75 Years | Chongqing Precision Biotech Co., Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
